Jefferies Keeps Their Buy Rating on British American Tobacco (BATS)
Jefferies analyst Andrei Andon Ionita maintained a Buy rating on British American Tobacco today and set a price target of £52.00.
Introducing TipRanks MCP for Agents
- Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools.
- Designed for personal research, portfolio monitoring, and AI-assisted investment workflows.
Andon Ionita covers the Consumer Defensive sector, focusing on stocks such as British American Tobacco, Imperial Brands, and Japan Tobacco. According to TipRanks, Andon Ionita has an average return of -2.2% and a 47.83% success rate on recommended stocks.
In addition to Jefferies, British American Tobacco also received a Buy from Morgan Stanley’s David Roux in a report issued yesterday. However, on June 2, RBC Capital maintained a Sell rating on British American Tobacco (LSE: BATS).
Based on British American Tobacco’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of p13.54 billion and a net profit of p3.25 billion. In comparison, last year the company earned a revenue of p13.53 billion and had a GAAP net loss of p1.45 billion
Based on the recent corporate insider activity of 74 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of BATS in relation to earlier this year.
Read More on GB:BATS:
Disclaimer & DisclosureReport an Issue
- British American Tobacco price target raised to 4,950 GBp at Morgan Stanley
- BAT cancels 620,000 shares in latest buyback tranche
- British American Tobacco Reports Insider-Related Share Purchase
- BAT chief executive boosts stake with £215,300 share purchase
- BAT executives add shares through UK-approved incentive plan
